Pfizer and BioNTech shares rose sharply on Monday by 4% and 10%, respectively. This happened after the US Food and Drug Administration (FDA) assigned an “accelerated” status to their two COVID-19 potential vaccines.
Although the companies have not yet completed the final tests and have not received approval for the production and sale of their vaccine, the status gives them a chance to accelerate the transition to these stages. It also gives a chance that their vaccine will receive a FDA “priority review” status, which means that management can decide on approval within six months.
In early July, they said that phase 2 of clinical trials of a vaccine BNT162b1 showed that all 24 volunteers who received two injections had a “strong immune response” to the virus. It was even stronger than that patients who underwent COVID-19 had.
While data on these trials is due to be released this month, today Pfizer and BioNTech intend to move on to testing the most promising of the potential vaccines with up to 30,000 participants in the United States and Europe.
“The FDA’s decision to grant these two COVID-19 vaccines an ‘accelerated status’ is an important milestone in efforts to develop a safe and effective SARS-CoV-2 vaccine,” said Peter Honig, Pfizer’s Senior Vice President of global regulation. “We look forward to continuing to work closely with the FDA throughout the clinical development of this Project Lightspeed program to evaluate the safety and efficiency of these vaccines.”
According to Pfizer, if regulators eventually approve the drug, Pfizer and BioNTech will deliver up to 100 million doses by the end of the year and at least another 1.2 billion by the end of 2021.
Moderna which is developing a potential vaccine using technology similar to Pfizer and BioNTech received the same “accelerated” status in May for its COVID-19 vaccine candidate.
Moderna shares jumped 14.65% on Monday because of the news that they will be added to the Nasdaq-100 index before the market opens on July 20.
Analysts estimate the potential annual revenue from global COVID-19 vaccine sales at $5 to $10 billion.
Міністерство охорони здоров’я Канади схвалило використання вакцини від коронавірусної інфекції компаній Pfizer і BioNTech, оскільки препарат “відповідає найсуворішим вимогам безпеки, ефективності та якості”, пише ТАСС з посиланням на сайт відомства. Зазначається, що в розділі Вакцинація від коронавірусу навпроти даних про вакцину Pfizer/BioNTech стоїть напис: “Схвалено 9 грудня 2020 року”. У МОЗ підкреслили, що спочатку фахівці […]
Shares of Pfizer and BioNTech fell 1.74% and 2% (respectively) on Thursday amid news that companies will deliver half of their planned number of vaccines against COVID-19 in 2020. On November 20, Pfizer and its German partner BioNTech applied to the FDA (US Food and Drug Administration) for permission to use their vaccine in an […]
Китайський розробник і виробник вакцини проти COVID-19 Sinovac Biotech оголосив у понеділок про продаж 15% в своєму підрозділі Sinovac Life Sciences. Частка продана одному з найбільших в Китаї виробників дженериків Sino Biopharmaceutical приблизно за $500 млн. Тим самим, як повідомила компанія, Sinovac забезпечила себе засобами, необхідними для виробництва вакцини CoronaVac. Домовленість щодо угоди була досягнута […]
Американська біотехнологічна компанія, сфокусована на розробці ліків і вакцин, розкрила нові подробиці про очікувані постачання своєї вакцини від COVID-19. Так, компанія зможе надати вакцини для імунізації до 60 мільйонів осіб в США і 12,5 мільйона за межами країни до кінця березня, пише The Wall Street Journal. Представники Moderna заявили, що в цьому місяці збираються в […]
The mRNA-1273 vaccine from the American company Moderna will be tested on three thousand children in six US states. CNN reported this on Wednesday, December 2. “Moderna has started inviting children over the age of 12 to try the vaccine” the statement said. It is noted that the study will involve volunteers aged 12-18 from […]
Following the third phase of trials of its COVID-19 coronavirus vaccine, Moderna said the drug was generally well tolerated and no serious health problems were identified. According to the company, the effectiveness of its vaccine reaches 94.1%, and 100% for preventing severe coronavirus cases. Previously, the manufacturer estimated the effectiveness of its drug at 94.5%. […]
Європейська комісія (ЄК) повідомила, що схвалила шостий контракт в рамках стратегії Євросоюзу щодо вакцин проти коронавірусу. Це контракт з американською фармацевтичною компанією Moderna, його сума не називається. За умовами угоди спочатку ЄС закупить 80 млн доз і зможе запросити ще стільки ж після того, як буде доведена ефективність і безпека вакцини. «Я дуже рада оголосити […]
МОЗ веде переговори з шістьма компаніями з постачання вакцини від COVID-19 в Україні. Про це заявив глава МОЗ Максим Степанов. Зараз Україна веде переговори з усіма виробниками вакцини від коронавірусу, так як за рахунок однієї компанії МОЗ не зможе забезпечити вакциною все населення країни, говорить міністр. “Ми вже на етапі підписання відповідних документів. Це компанія […]
JPMorgan shares increased because of the announcement of financial results for the 2nd quarter ended on June 30. Since the beginning of the year, JPMorgan shares have lost almost 30% because the global COVID-19 pandemic has hit the global economy, and the US Federal Reserve has cut rates to zero greatly reducing the profitability of […]
Next
Agricultural holding “Industrial Milk Company” (IMC) is planning to raise $ 20 million funding from the European Bank for Reconstruction and Development for appending of the floating capital. According to the bank’s website, the board of directors plans to consider the relevant draft at the meeting on April 20. The total cost of the project […]
Next
The Council of the European Union is set to approve two EU legislative acts on Tuesday, February 24, providing Ukraine with a €90 billion loan. The measures will allow technical work on the loan to continue even as Hungary blocks a third bill required to complete the process. This was stated by European Commissioner Valdis […]
Next
Shares of Zoom Video Communications, which rose 716% over the past 12 months, rose 5.8% during trading on Monday, but closed with an increase of 1.23%. This is very different from the general decline in the market on Monday – major US stock indexes closed lower: the S&P 500 by 1.86%, the Dow Jones by […]
Next
Microsoft will stop supporting Windows 10 on October 14, 2025. This was reported by the company’s press service. Thurrot writes that this means the date of the “death” of Windows 10. The publication adds that the new generation of operating system, which Microsoft will present next week, will not be called Windows 10, at least, […]
Next
The Digital Future Investment company became a co-investor in the startup YouAppi round “B”. According to the CEO of the Digital Future, Alexei Vitchenko, this is the first transaction of the Ukrainian investment company in the “B” round level. The deposit amount is not disclosed. American-Israel YouAppi service was founded in 2011. YouAppi technology is […]
Next
In temporarily occupied Crimea, gas stations have restricted the sale of AI-95 gasoline due to shortages, The Moscow Times reports. According to local residents, this type of fuel has disappeared from most stations, while at those where it is still available, sales are mostly made using vouchers issued by companies. The price of AI-95 has […]
Next
The European automotive market began 2026 in decline: in EU countries, the United Kingdom, and the European Free Trade Association (EFTA), 961,382 new cars were registered in January — 3.5% fewer than a year earlier, according to Carscoops. Sales of Tesla in the region fell by 17% to 8,075 vehicles. The company’s market share declined […]
Next
In the United States, Ford Motor Company announced a large-scale recall of nearly 500,000 Ford Edge and Lincoln MKX vehicles and more than 105,000 Mustang vehicles. According to Reuters, the first recall is due to a possible malfunction in the braking system, while the second is due to a failure of the exterior lighting. In […]
Next
Shares of Pfizer and BioNTech fell 1.74% and 2% (respectively) on Thursday amid news that companies will deliver half of their planned number of vaccines against COVID-19 in 2020. On November 20, Pfizer and its German partner BioNTech applied to the FDA (US Food and Drug Administration) for permission to use their vaccine in an […]
Next
Ukrainian companies need to boldly experiment with artificial intelligence (AI). Success will belong not to those with the most powerful model, but to those who integrate it most effectively into their processes. This was discussed during a panel at this year’s Forbes Tech 2025, according to the press service of Metinvest. The discussion featured Oleksii […]
Next
For the three quarters of 2021, the budget was overfulfilled in terms of revenues by 5.3%, or UAH 46.65 billion, from the plan and exceeds last year’s level by 20.8%. This was reported on the website of the State Treasury. In particular, in September the budget was overfulfilled by 6.4%, or UAH 6.2 billion, and […]
Next
The United States has given Germany a six-month deadline to resolve the issue of Rosneft’s German assets, allowing them to be temporarily exempted from U.S. sanctions, Bloomberg reported, citing informed sources. The Trump administration has indicated to Berlin that it is considering issuing a limited, non-renewable general license for Rosneft Deutschland. German authorities are currently […]
Next
Hyundai Motor Company and General Motors have unveiled initial plans for five jointly developed vehicles. Four of the vehicles — a compact crossover, a sedan, a pickup truck, and a mid-size pickup — are targeted at markets in Central and South America. All models will be available with both gasoline engines and hybrid powertrains. The […]
Next
TUI will receive another 1.2 billion euros in state aid in connection with the effects of the coronavirus pandemic, the press service of the travel concern said. “The € 1.2 billion stabilization package strengthens the group’s position, providing sufficient liquidity in an unstable market environment. This applies to both the tourist season of the winter […]
Next
Rising prices for memory chips are significantly affecting the production cost of smartphones. According to analysts at Counterpoint Research, in the first quarter of 2026 the cost of memory for manufacturers of budget smartphones could increase by 25%, reaching about 43% of the total cost of components. This estimate is based on a typical configuration […]
Next
